Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (48 ops.)
Latest filing published 07 Jul 2026 for Regeneron Pharmaceuticals, INC., €114k. Read the official filing
Filing timeline
BuySaleArthur F. Ryan
Insider track record
Disclosed buys
0
Disclosed sells
48
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Arthur F. Ryan: trading record in brief
All filings by Arthur F. Ryan on record concern Regeneron Pharmaceuticals, Inc., in the capacity of board member. In total, 53 filings cover trades dated from 5 November 2015 to 2 July 2026.
Every open-market trade on record is a sale: 48 sales worth €283k. Besides market trades, the filings include 2 share grants. Since January 2026: no purchases and 12 sales on the market.
Most recently, on 7 July 2026, the filings show an open-market sale worth €114k in Regeneron Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Arthur F. Ryan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations53 total
200 shares@ US$650.150.0002% mcap49.2% of flowCommon StockSEC:0001187443-26-000010:0
1 shares@ US$771.320.2% of flowCommon StockSEC:0001104659-26-039613:0
3 shares@ US$772.760.7% of flowCommon StockSEC:0001104659-26-039613:1
8 shares@ US$773.591.8% of flowCommon StockSEC:0001104659-26-039613:2
8 shares@ US$774.581.8% of flowCommon StockSEC:0001104659-26-039613:3
14 shares@ US$775.583.1% of flowCommon StockSEC:0001104659-26-039613:4
13 shares@ US$776.622.9% of flowCommon StockSEC:0001104659-26-039613:5
9 shares@ US$777.422.0% of flowCommon StockSEC:0001104659-26-039613:6
4 shares@ US$778.240.9% of flowCommon StockSEC:0001104659-26-039613:7
40 shares@ US$779.719.0% of flowCommon StockSEC:0001104659-26-039613:8
7 shares@ US$777.461.6% of flowCommon StockSEC:0001187443-26-000006:0
1 shares@ US$775.630.2% of flowCommon StockSEC:0001187443-26-000004:0
155 shares0Common StockSEC:0001187443-26-000002:0
166 shares0Common StockSEC:0001968202-25-000007:0
3 shares@ US$1,041.352.4% of flowCommon StockSEC:0001968202-24-000130:0
4 shares@ US$1,166.523.6% of flowCommon StockSEC:0001968202-24-000124:0
1 shares@ US$1,100.030.9% of flowCommon StockSEC:0001968202-24-000111:0
1 shares@ US$1,053.220.8% of flowCommon StockSEC:0001968202-24-000110:0
3 shares@ US$1,047.112.5% of flowCommon StockSEC:0001968202-24-000105:0
2 shares@ US$979.401.5% of flowCommon StockSEC:0001968202-24-000099:0
3 shares@ US$889.502.1% of flowCommon StockSEC:0001883850-24-000017:0
2 shares@ US$957.781.5% of flowCommon StockSEC:0001968202-24-000090:0
1 shares@ US$967.500.8% of flowCommon StockSEC:0001968202-24-000084:0
1 shares@ US$939.530.7% of flowCommon StockSEC:0001968202-24-000048:0
1 shares@ US$873.910.7% of flowCommon StockSEC:0001968202-24-000025:0
25 of 53 declarations
